July 2014 FDA Recall Sodium Chloride by Baxter Healthcare Corp.
D-1583-2014 - Lack of Assurance of Sterility; complaints of mold in the overpouch
This Class II drug recall was voluntarily initiated by Baxter Healthcare Corp. on July 30, 2014 for the product Sodium Chloride. The FDA reported the reason for recall as lack of assurance of sterility; complaints of mold in the overpouch. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1583-2014
Lack of Assurance of Sterility; complaints of mold in the overpouch
07-30-2014
09-17-2014
157,080 containers
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Baxter Healthcare Corp.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
06-08-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-0049-03
Batch or Lot Expiration Information
Lot# C926642, Product Code: 2B1323N
